(Q51987968)

19 April 2018

title

Lymphocyte homeostasis following therapeutic lymphocyte depletion in multiple sclerosis. (English)

1 reference

19 April 2018

0 references

Herman Waldmann

6

0 references

Geoff Hale

5

object named as

Geoff Hale

1 reference

19 April 2018

author name string

Amanda L Cox

1

1 reference

19 April 2018

Sara A J Thompson

2

1 reference

19 April 2018

Joanne L Jones

3

1 reference

19 April 2018

Vicki H Robertson

4

1 reference

19 April 2018

D Alastair S Compston

7

1 reference

19 April 2018

Alasdair J Coles

8

1 reference

19 April 2018

language of work or name

English

0 references

publication date

1 November 2005

1 reference

19 April 2018

European Journal of Immunology

published in

1 reference

19 April 2018

volume

35

1 reference

19 April 2018

page(s)

3332-3342

1 reference

19 April 2018

issue

11

1 reference

19 April 2018

The many faces of IL-7: from lymphopoiesis to peripheral T cell maintenance

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535075

Effects of anti-CD4 antibody treatment on lymphocyte subsets and stimulated tumor necrosis factor alpha production: a study of 29 multiple sclerosis patients entered into a clinical trial of cM-T412

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535075

A repressor of GATA-mediated negative feedback mechanism of T cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535075

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535075

Characterization of the CAMPATH-1 (CDw52) antigen: biochemical analysis and cDNA cloning reveal an unusually small peptide backbone

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535075

7 January 2021

Monoclonal antibody treatment exposes three mechanisms underlying the clinical course of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535075

7 January 2021

Blood concentrations of alemtuzumab and antiglobulin responses in patients with chronic lymphocytic leukemia following intravenous or subcutaneous routes of administration.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535075

7 January 2021

Total lymphoid irradiation in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535075

7 January 2021

Morbidity and mortality in rheumatoid arthritis patients with prolonged and profound therapy-induced lymphopenia

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535075

7 January 2021

Interleukin-7 deficiency in rheumatoid arthritis: consequences for therapy-induced lymphopenia

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535075

7 January 2021

Age-dependent incidence, time course, and consequences of thymic renewal in adults

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535075

7 January 2021

Phenotypic and functional lymphocyte recovery after CD34+-enriched versus non-T cell-depleted autologous peripheral blood stem cell transplantation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535075

7 January 2021

Factors that influence long-term hematopoietic function following autologous stem cell transplantation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535075

7 January 2021

Maintenance therapy with a monthly injection of alemtuzumab prolongs response duration in patients with refractory B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma (B-CLL/SLL).

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535075

7 January 2021

Cellular immune reconstitution after subcutaneous alemtuzumab (anti-CD52 monoclonal antibody, CAMPATH-1H) treatment as first-line therapy for B-cell chronic lymphocytic leukaemia

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535075

7 January 2021

A ligand for the chemokine receptor CCR7 can influence the homeostatic proliferation of CD4 T cells and progression of autoimmunity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535075

7 January 2021

Maintaining the norm: T-cell homeostasis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535075

7 January 2021

Homeostasis of alpha beta TCR+ T cells.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535075

7 January 2021

Designing and maintaining the mature TCR repertoire: the continuum of self-peptide:self-MHC complex recognition

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535075

7 January 2021

CD4+ T cell survival is not directly linked to self-MHC-induced TCR signaling

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535075

7 January 2021

Self-recognition and the regulation of CD4+ T cell survival.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535075

7 January 2021

Exogenous IL-7 increases recent thymic emigrants in peripheral lymphoid tissue without enhanced thymic function.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535075

7 January 2021

Distinct regions of the interleukin-7 receptor regulate different Bcl2 family members

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535075

7 January 2021

Interleukin-7: from bench to clinic

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535075

7 January 2021

A potential role for interleukin-7 in T-cell homeostasis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535075

7 January 2021

Serum levels of IL-7 in bone marrow transplant recipients: relationship to clinical characteristics and lymphocyte count

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535075

7 January 2021

Treatment with soluble interleukin-15Ralpha exacerbates intracellular parasitic infection by blocking the development of memory CD8+ T cell response

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535075

7 January 2021

Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535075

7 January 2021

Interleukin-15 enhances immune reconstitution after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535075

7 January 2021

Control of homeostasis of CD8+ memory T cells by opposing cytokines.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535075

7 January 2021

Interleukin 15 is required for proliferative renewal of virus-specific memory CD8 T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535075

7 January 2021

Interleukin (IL)-15 and IL-7 jointly regulate homeostatic proliferation of memory phenotype CD8+ cells but are not required for memory phenotype CD4+ cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535075

7 January 2021

CD4+CD25high regulatory cells in human peripheral blood

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535075

7 January 2021

Cutting edge: self-peptides drive the peripheral expansion of CD4+CD25+ regulatory T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535075

7 January 2021

Control of regulatory T cell development by the transcription factor Foxp3

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535075

7 January 2021

Homeostatic T cell proliferation in a T cell-dendritic cell coculture system

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535075

7 January 2021

Ex vivo homeostatic proliferation of CD4+ T cells in rheumatoid arthritis is dysregulated and driven by membrane-anchored TNFalpha

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535075

7 January 2021

Flow cytometric analysis of cell division history using dilution of carboxyfluorescein diacetate succinimidyl ester, a stably integrated fluorescent probe.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535075

7 January 2021

A flow cytometric method to estimate the precursor frequencies of cells proliferating in response to specific antigens.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535075

7 January 2021

Repopulation of blood lymphocyte sub-populations in rheumatoid arthritis patients treated with the depleting humanized monoclonal antibody, CAMPATH-1H

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535075

7 January 2021

Homeostatic proliferation is a barrier to transplantation tolerance

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535075

7 January 2021

Homeostasis-stimulated proliferation drives naive T cells to differentiate directly into memory T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535075

7 January 2021

Foxp3 programs the development and function of CD4+CD25+ regulatory T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535075

7 January 2021

Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535075

7 January 2021

Naive T cells transiently acquire a memory-like phenotype during homeostasis-driven proliferation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535075

7 January 2021

T cell receptor excision circles as markers for recent thymic emigrants: basic aspects, technical approach, and guidelines for interpretation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535075

7 January 2021

Pulsed monoclonal antibody treatment and autoimmune thyroid disease in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535075

7 January 2021

ROG negatively regulates T-cell activation but is dispensable for Th-cell differentiation.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535075

7 January 2021

ROG, repressor of GATA, regulates the expression of cytokine genes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535075

7 January 2021

Serial analysis of gene expression provides new insights into regulatory T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535075

7 January 2021

Suppression of IL7Rα Transcription by IL-7 and Other Prosurvival Cytokines

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535075

7 January 2021

Transient increase in symptoms associated with cytokine release in patients with multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535075

7 January 2021

Identifiers

DOI

10.1002/EJI.200535075

1 reference

19 April 2018

PubMed ID

16231285

1 reference

19 April 2018